Home › Companies › Y-MABS THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and Y-MABS THERAPEUTICS INC.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 11, 2024: 5 items on Y-MABS THERAPEUTICS INC.’s Form 8-K, filed June 13, 2024: 3 elected · 2 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2025-2026
Explore Y-MABS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are Y-MABS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael Rossi | 28,429,656 | -- | -- | 65,392 | 3,466,788 | 99.7% | Elected | — |
| Elect Director: Thomas Gad | 21,845,733 | -- | -- | 6,649,315 | 3,466,788 | 77% | Elected | — |
| Elect Director: Johan Wedell-Wedellsborg | 21,920,196 | -- | -- | 6,574,852 | 3,466,788 | 77% | Elected | — |
| 2. Ratification of the Appointment of the Independent Registered Public Accounting Firm | 31,959,182 | 2,489 | 164 | -- | -- | 99.9% | Approved | — |
| 3. Advisory Vote on the Compensation of the Named Executive Officers | 27,772,834 | 721,693 | 521 | -- | 3,466,788 | 97% | Approved | — |
Source: Y-MABS THERAPEUTICS INC., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.
Each item below shows how the 137 asset managers that disclosed a Y-MABS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Johan Wedell-Wedellsborg
Y-MABS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Johan Wedell-Wedellsborg”): 21,920,196 for, 6,574,852 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The Company's stockholders elected the three persons listed below as directors, each to serve until the Company's 2027 Annual Meeting of Stockholders, subject to the election and qualification of his or her successor or to his or her earlier death, resignation or …”
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 4,032,646 for, 608,583 withheld, 44,235 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,004,435 | 0 | 0 | 0 | For |
| BlackRock | 950,721 | 0 | 0 | 0 | For |
| Fidelity | 457,504 | 0 | 0 | 0 | For |
| Charles Schwab | 250,537 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 184,618 | Withhold |
| Equitable | 120,603 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 82,188 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 80,759 | Withhold |
| SEI | 65,840 | 0 | 0 | 0 | For |
| Lincoln Financial | 472 | 0 | 0 | 49,179 | Withhold |
| Nationwide | 359 | 0 | 0 | 47,423 | Withhold |
| American Century | 0 | 0 | 0 | 46,982 | Withhold |
| TIAA | 40,732 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 25,685 | Withhold |
| Federated Hermes | 25,345 | 0 | 0 | 0 | For |
| Global X | 25,001 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 18,713 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 0 | 16,463 | 0 | Abstain |
| AQR | 0 | 0 | 0 | 15,930 | Withhold |
| CLEARWATER INVESTMENT TRUST | 15,137 | 0 | 0 | 0 | For |
| Legg Mason | 0 | 0 | 0 | 14,879 | Withhold |
| John Hancock | 0 | 0 | 14,567 | 0 | Abstain |
| HC CAPITAL TRUST | 0 | 0 | 0 | 14,136 | Withhold |
| Pacific Life | 13,223 | 0 | 0 | 0 | For |
| Voya | 12,781 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael Rossi
Y-MABS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Rossi”): 28,429,656 for, 65,392 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The Company's stockholders elected the three persons listed below as directors, each to serve until the Company's 2027 Annual Meeting of Stockholders, subject to the election and qualification of his or her successor or to his or her earlier death, resignation or …”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 4,649,819 for, 27,239 withheld, 8,406 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,004,435 | 0 | 0 | 0 | For |
| BlackRock | 950,721 | 0 | 0 | 0 | For |
| Fidelity | 457,504 | 0 | 0 | 0 | For |
| Charles Schwab | 250,537 | 0 | 0 | 0 | For |
| Goldman Sachs | 184,618 | 0 | 0 | 0 | For |
| Equitable | 120,603 | 0 | 0 | 0 | For |
| MFS | 82,188 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 80,759 | 0 | 0 | 0 | For |
| SEI | 65,840 | 0 | 0 | 0 | For |
| Lincoln Financial | 48,097 | 0 | 0 | 1,554 | For |
| Nationwide | 47,782 | 0 | 0 | 0 | For |
| American Century | 46,982 | 0 | 0 | 0 | For |
| TIAA | 40,732 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 25,685 | Withhold |
| Federated Hermes | 25,345 | 0 | 0 | 0 | For |
| Global X | 25,001 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 18,713 | 0 | 0 | 0 | For |
| ETF Series Solutions | 16,463 | 0 | 0 | 0 | For |
| AQR | 15,930 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 15,137 | 0 | 0 | 0 | For |
| Legg Mason | 14,879 | 0 | 0 | 0 | For |
| John Hancock | 14,567 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 14,136 | 0 | 0 | 0 | For |
| Pacific Life | 13,223 | 0 | 0 | 0 | For |
| Voya | 12,781 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 3 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Thomas Gad
Y-MABS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Thomas Gad”): 21,845,733 for, 6,649,315 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The Company's stockholders elected the three persons listed below as directors, each to serve until the Company's 2027 Annual Meeting of Stockholders, subject to the election and qualification of his or her successor or to his or her earlier death, resignation or …”
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 3,957,945 for, 683,284 withheld, 44,235 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,004,435 | 0 | 0 | 0 | For |
| BlackRock | 950,721 | 0 | 0 | 0 | For |
| Fidelity | 457,504 | 0 | 0 | 0 | For |
| Charles Schwab | 250,537 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 184,618 | Withhold |
| Equitable | 58,683 | 0 | 0 | 61,920 | Mixed |
| MFS | 0 | 0 | 0 | 82,188 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 80,759 | Withhold |
| SEI | 65,840 | 0 | 0 | 0 | For |
| Lincoln Financial | 472 | 0 | 0 | 49,179 | Withhold |
| Nationwide | 359 | 0 | 0 | 47,423 | Withhold |
| American Century | 0 | 0 | 0 | 46,982 | Withhold |
| TIAA | 40,732 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 25,685 | Withhold |
| Federated Hermes | 25,345 | 0 | 0 | 0 | For |
| Global X | 25,001 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 18,713 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 0 | 16,463 | 0 | Abstain |
| AQR | 0 | 0 | 0 | 15,930 | Withhold |
| CLEARWATER INVESTMENT TRUST | 15,137 | 0 | 0 | 0 | For |
| Legg Mason | 0 | 0 | 0 | 14,879 | Withhold |
| John Hancock | 0 | 0 | 14,567 | 0 | Abstain |
| HC CAPITAL TRUST | 0 | 0 | 0 | 14,136 | Withhold |
| Pacific Life | 13,223 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 12,781 | Withhold |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 7 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON A NON-BINDING ADVISORY VOTE BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY MATERIALS.
Y-MABS THERAPEUTICS INC.’s own tally for this item (“3. Advisory Vote on the Compensation of the Named Executive Officers”): 27,772,834 for, 721,693 against — passed, per its Form 8-K filed June 13, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Advisory Vote on the Compensation of the Named Executive Officers The Company's stockholders approved Proposal 3.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,004,435 | 0 | 0 | 0 | For |
| BlackRock | 950,721 | 0 | 0 | 0 | For |
| Fidelity | 457,504 | 0 | 0 | 0 | For |
| Charles Schwab | 250,537 | 0 | 0 | 0 | For |
| Goldman Sachs | 184,618 | 0 | 0 | 0 | For |
| Equitable | 120,603 | 0 | 0 | 0 | For |
| MFS | 82,188 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 80,759 | 0 | 0 | Against |
| SEI | 0 | 65,840 | 0 | 0 | Against |
| Lincoln Financial | 48,097 | 1,554 | 0 | 0 | For |
| Nationwide | 47,423 | 359 | 0 | 0 | For |
| American Century | 0 | 46,982 | 0 | 0 | Against |
| TIAA | 40,732 | 0 | 0 | 0 | For |
| Dimensional | 0 | 25,685 | 0 | 0 | Against |
| Federated Hermes | 25,345 | 0 | 0 | 0 | For |
| Global X | 0 | 25,001 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 18,713 | 0 | 0 | 0 | For |
| ETF Series Solutions | 16,463 | 0 | 0 | 0 | For |
| AQR | 15,930 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 15,137 | 0 | 0 | Against |
| Legg Mason | 14,879 | 0 | 0 | 0 | For |
| John Hancock | 14,567 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 0 | 14,136 | 0 | 0 | Against |
| Pacific Life | 13,223 | 0 | 0 | 0 | For |
| Voya | 12,781 | 0 | 0 | 0 | For |
Fund voting reports, all 51 managers: 4,384,238 for, 302,522 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 2,288,643 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 2,194,278 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 1,831,000 | 0 | 0 | 0 | For |
| Point72 | 1,221,592 | 0 | 0 | 0 | For |
| DE Shaw | 857,000 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 774,200 | 0 | 0 | 0 | For |
| BlackRock | 629,024 | 3,404 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 538,563 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 473,565 | 0 | 0 | 0 | For |
| State Street | 400,859 | 781 | 0 | 0 | For |
| Caligan Partners LP | 260,702 | 0 | 0 | 0 | For |
| Charles Schwab | 250,537 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 220,809 | 0 | 0 | 0 | For |
| Northern Trust | 145,546 | 35 | 0 | 0 | For |
| Wellington | 0 | 132,643 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 123,118 | 0 | 0 | 0 | For |
| Goldman Sachs | 121,203 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 118,681 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 100,251 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 82,188 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 80,759 | 0 | 0 | Against |
| RICE HALL JAMES & ASSOCIATES, LLC | 0 | 78,059 | 0 | 0 | Against |
| SEI | 0 | 66,729 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 64,725 | 0 | 0 | Against |
| AllianceBernstein | 61,920 | 0 | 0 | 0 | For |
Institutional-manager reports, all 103 managers: 13,323,657 for, 631,056 against. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.
Y-MABS THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the Appointment of the Independent Registered Public Accounting Firm”): 31,959,182 for, 2,489 against — passed, per its Form 8-K filed June 13, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Ratification of the Appointment of the Independent Registered Public Accounting Firm The Company's stockholders approved Proposal 2.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 4,685,464 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,004,435 | 0 | 0 | 0 | For |
| BlackRock | 950,721 | 0 | 0 | 0 | For |
| Fidelity | 457,504 | 0 | 0 | 0 | For |
| Charles Schwab | 250,537 | 0 | 0 | 0 | For |
| Goldman Sachs | 184,618 | 0 | 0 | 0 | For |
| Equitable | 120,603 | 0 | 0 | 0 | For |
| MFS | 82,188 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 80,759 | 0 | 0 | 0 | For |
| SEI | 65,840 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,651 | 0 | 0 | 0 | For |
| Nationwide | 47,782 | 0 | 0 | 0 | For |
| American Century | 46,982 | 0 | 0 | 0 | For |
| TIAA | 40,732 | 0 | 0 | 0 | For |
| Dimensional | 25,685 | 0 | 0 | 0 | For |
| Federated Hermes | 25,345 | 0 | 0 | 0 | For |
| Global X | 25,001 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 18,713 | 0 | 0 | 0 | For |
| ETF Series Solutions | 16,463 | 0 | 0 | 0 | For |
| AQR | 15,930 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 15,137 | 0 | 0 | 0 | For |
| Legg Mason | 14,879 | 0 | 0 | 0 | For |
| John Hancock | 14,567 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 14,136 | 0 | 0 | 0 | For |
| Pacific Life | 13,223 | 0 | 0 | 0 | For |
| Voya | 12,781 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 43,882,638 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.57% |
| 2 | BlackRock | 2.17% |
| 3 | Fidelity | 1.04% |
| 4 | Charles Schwab | 0.57% |
| 5 | Goldman Sachs | 0.42% |
| 6 | Equitable | 0.27% |
| 7 | MFS | 0.19% |
| 8 | BRIDGEWAY FUNDS INC | 0.18% |
| 9 | SEI | 0.15% |
| 10 | Lincoln Financial | 0.11% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Paradigm Biocapital Advisors LP | 5.22% |
| 2 | Sofinnova Investments, Inc. | 5.00% |
| 3 | Polar Capital Holdings Plc | 4.17% |
| 4 | Point72 | 2.78% |
| 5 | DE Shaw | 1.95% |
| 6 | PICTET ASSET MANAGEMENT SA | 1.76% |
| 7 | BlackRock | 1.44% |
| 8 | Soleus Capital Management, L.P. | 1.23% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.08% |
| 10 | State Street | 0.92% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| The Vanguard Group | 5.11% | 13G |
| Point72 | 3.48% | 13F |
| D.E. Shaw | 2.43% | 13F |
| State Street | 1.71% | 13F |
| Geode Capital | 1.69% | 13F |
| Dimensional Fund Advisors | 0.95% | 13F |
| Northern Trust | 0.73% | 13F |
| Millennium Management | 0.64% | 13F |
| Nuveen | 0.61% | 13F |
| Charles Schwab | 0.57% | 13F |
Percentages above are of 43,882,638 shares outstanding, as reported by Y-MABS THERAPEUTICS INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Y-MABS THERAPEUTICS INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Y-MABS THERAPEUTICS INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 137 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 902 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING ADVISORY VOTE BASIS, THE COMPENSATION OF THE COMPANY'S NAMED… — Y-MABS THERAPEUTICS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Y-MABS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2024.
Y-MABS THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.